Particle.news

Download on the App Store

Nucleus Genomics Unveils IVF Embryo Ranking by IQ, Health and Traits

The company uses polygenic scoring from partner lab Genomic Prediction to forecast probabilities for cognitive ability, chronic disease or physical traits without federal oversight.

Vitro Fertilization. IVF and Human fetus with DNA strand. 3d illustration
Embyro Selection from DNA Testing of 900+ Genes – IQ, Longevity and More
Parents Can Choose Genetic Makeup of Their Children With New IVF Option
Image

Overview

  • The $5,999 Nucleus Embryo service lets parents upload up to 20 embryo genomes for analysis across nearly 900 health and trait markers.
  • Using whole-genome data from partner Genomic Prediction, the platform generates polygenic risk scores to estimate projected IQ, height, eye color and risk for cancers, Alzheimer’s and other diseases.
  • CEO Kian Sadeghi frames the tool as part of the longevity movement, arguing that early genetic insights can reduce chronic disease and extend healthy lifespan.
  • Company materials acknowledge that trait forecasts are probabilistic and “limited in accuracy,” with IQ predictions attracting particular scrutiny.
  • Bioethicists warn that the unregulated ranking system could encourage societal preferences for certain children and revive modern eugenics concerns.